Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome
Marit Jalink(Leiden University Medical Center), Josephine M. I. Vos(Sanquin), Efstathios Kastritis(National and Kapodistrian University of Athens), Henrik Frederiksen(University of Southern Denmark), Jorge J. Castillo(Dana-Farber Cancer Institute), Andrea Patriarca(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Masja de Haas(Dutch Blood Transfusion Society), Ramona Cassin(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Sigbjørn Berentsen(Privatsykehuset Haugesund), Liesbeth E.M. Oosten(Leiden University Medical Center), Bruno Fattizzo(University of Milan), Steven P. Treon(Dana-Farber Cancer Institute), Marjan Cruijsen(Radboud University Nijmegen), Despina Fotiou(National and Kapodistrian University of Athens), Shirley D’Sa(University College Hospital)
Cited by 56
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
|Blood|2001|905